Immuneering Corp - Ordinary Shares Class A
IMRX
Market Cap$43M
Close$
$1.93
21.6% upside
Current Fair Value
21.6% upsideUndervalued by 21.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $43.00 Million |
|---|---|
| Enterprise Value | $-49,702,494.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.86 |
| Beta | 2.37 |
| Outstanding Shares | 29,653,355 |
| Avg 30 Day Volume | 412,332 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.83 |
|---|---|
| PEG | 42.93 |
| Price to Sales | - |
| Price to Book Ratio | 0.53 |
| Enterprise Value to Revenue | -109236.25 |
| Enterprise Value to EBIT | 0.89 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.09 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
ESG Score
No data
About Immuneering Corp
2,021 employees